Gene Expression Profiling Identifies IRF4-Associated Molecular Signatures in Hematological Malignancies
暂无分享,去创建一个
Yanji Xu | J. Moorman | Ling Wang | Z. Yao | S. Ning | Shunbin Ning
[1] Alexander S. Banks,et al. IRF4 Is a Key Thermogenic Transcriptional Partner of PGC-1α , 2014, Cell.
[2] Theresa Guo,et al. A Polymorphism in IRF4 Affects Human Pigmentation through a Tyrosinase-Dependent MITF/TFAP2A Pathway , 2013, Cell.
[3] K. Murphy,et al. Specificity through cooperation: BATF–IRF interactions control immune-regulatory networks , 2013, Nature Reviews Immunology.
[4] Ling Wang,et al. Interferon Regulatory Factor 4 Is Activated through c-Src-Mediated Tyrosine Phosphorylation in Virus-Transformed Cells , 2013, Journal of Virology.
[5] S. Ning,et al. IRF4 as an Oncogenic Biomarker for Hematological Malignancies , 2013 .
[6] Ling Wang,et al. IRF4 Is Activated through c-Src-mediated Tyrosine , 2013 .
[7] M. Vieth,et al. GBP-1 acts as a tumor suppressor in colorectal cancer cells. , 2013, Carcinogenesis.
[8] G. Ribas,et al. Genetic variants in PARP1 (rs3219090) and IRF4 (rs12203592) genes associated with melanoma susceptibility in a Spanish population , 2013, BMC Cancer.
[9] S. Rutz,et al. A Genomic Regulatory Element That Directs Assembly and Function of Immune-Specific AP-1–IRF Complexes , 2012, Science.
[10] Lu Wang,et al. BATF-JUN is critical for IRF4-mediated transcription in T cells , 2012, Nature.
[11] Michael S. Behnke,et al. Compensatory dendritic cell development mediated by BATF-IRF interactions , 2012, Nature.
[12] A. Safa,et al. c-FLIP, a master anti-apoptotic regulator. , 2012, Experimental oncology.
[13] Paul Shinn,et al. Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma. , 2012, Cancer cell.
[14] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[15] Y. Hasegawa,et al. ARHGAP18, a GTPase-activating protein for RhoA, controls cell shape, spreading, and motility , 2011, Molecular biology of the cell.
[16] Roland Schmitz,et al. Malignant pirates of the immune system , 2011, Nature Immunology.
[17] Dirk Hasenclever,et al. Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults. , 2011, Blood.
[18] G. Barber,et al. Oncogenic IRFs Provide a Survival Advantage for Epstein-Barr Virus- or Human T-Cell Leukemia Virus Type 1-Transformed Cells through Induction of BIC Expression , 2011, Journal of Virology.
[19] Elaine Coustan-Smith,et al. New markers for minimal residual disease detection in acute lymphoblastic leukemia. , 2011, Blood.
[20] Dongsheng Xu,et al. Interferon Regulatory Factor 4 (IRF-4) Targets IRF-5 to Regulate Epstein-Barr Virus Transformation* , 2011, The Journal of Biological Chemistry.
[21] Merrick I Ross,et al. Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] Trevor J Pugh,et al. Initial genome sequencing and analysis of multiple myeloma , 2011, Nature.
[23] E. Borden,et al. Emerging roles of FAM14 family members (G1P3/ISG 6-16 and ISG12/IFI27) in innate immunity and cancer. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[24] Eun-Young Kim,et al. NFAT and IRF Proteins Regulate Transcription of the Anti-HIV Gene, APOBEC3G* , 2010, The Journal of Biological Chemistry.
[25] Nicole Soranzo,et al. IRF4 variants have age-specific effects on nevus count and predispose to melanoma. , 2010, American journal of human genetics.
[26] L. Weiss,et al. MUM1/IRF4: A Review , 2010, Applied immunohistochemistry & molecular morphology : AIMM.
[27] Tyson V. Sharp,et al. LIM-domain proteins, LIMD1, Ajuba, and WTIP are required for microRNA-mediated gene silencing , 2010, Proceedings of the National Academy of Sciences.
[28] G. Bhagat,et al. IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis? , 2010, Immunological reviews.
[29] J. Thierry-Mieg,et al. Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. , 2009, Immunity.
[30] S. Kakinuma,et al. Antiviral effects of the interferon‐induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein , 2009, Hepatology.
[31] L. Staudt,et al. IRF4: Immunity. Malignancy! Therapy? , 2009, Clinical Cancer Research.
[32] T. Molina,et al. Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome. , 2009, Blood.
[33] A. Lazar,et al. IFN regulatory factor 8 sensitizes soft tissue sarcoma cells to death receptor-initiated apoptosis via repression of FLICE-like protein expression. , 2009, Cancer research.
[34] A. Feldman,et al. Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas , 2008, Leukemia.
[35] Tyson V. Sharp,et al. The chromosome 3p21.3-encoded gene, LIMD1, is a critical tumor suppressor involved in human lung cancer development , 2008, Proceedings of the National Academy of Sciences.
[36] L. Staudt,et al. Stromal gene signatures in large-B-cell lymphomas. , 2008, The New England journal of medicine.
[37] R. Lu,et al. Interferon regulatory factor 4 and 8 in B-cell development. , 2008, Trends in immunology.
[38] Mark J. Smyth,et al. The TRAIL apoptotic pathway in cancer onset, progression and therapy , 2008, Nature Reviews Cancer.
[39] I. Andrulis,et al. Cell cycle regulated phosphorylation of LIMD1 in cell lines and expression in human breast cancers. , 2008, Cancer letters.
[40] L. Staudt,et al. IRF4 addiction in multiple myeloma , 2008, Nature.
[41] J. Miklossy,et al. Interferon Regulatory Factor 4 Is Involved in Epstein-Barr Virus-Mediated Transformation of Human B Lymphocytes , 2008, Journal of Virology.
[42] T. Taniguchi,et al. The IRF family transcription factors in immunity and oncogenesis. , 2008, Annual review of immunology.
[43] D. Leaman,et al. Mitochondrial localization and pro-apoptotic effects of the interferon-inducible protein ISG12a , 2008, Apoptosis.
[44] K. Basso,et al. A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. , 2007, Cancer cell.
[45] U. Certa,et al. Antiproliferative Activity of the Human IFN-α-Inducible Protein IFI44 , 2007 .
[46] D. Walls,et al. Manipulation of the Toll-Like Receptor 7 Signaling Pathway by Epstein-Barr Virus , 2007, Journal of Virology.
[47] S. Tsuzuki,et al. Genetic abnormalities involved in t(12;21) TEL–AML1 acute lymphoblastic leukemia: Analysis by means of array‐based comparative genomic hybridization , 2007, Cancer science.
[48] I. Lossos,et al. IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma. , 2007, Blood.
[49] U. Certa,et al. Antiproliferative activity of the human IFN-alpha-inducible protein IFI44. , 2007, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[50] W. Lucchesi,et al. Cell target genes of Epstein-Barr virus transcription factor EBNA-2: induction of the p55alpha regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cells. , 2006, The Journal of general virology.
[51] D. Schadendorf,et al. Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. , 2006, Pigment cell research.
[52] Richard Simon,et al. Molecular diagnosis of Burkitt's lymphoma. , 2006, The New England journal of medicine.
[53] R. Spang,et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. , 2006, The New England journal of medicine.
[54] Adam A. Margolin,et al. Reverse engineering of regulatory networks in human B cells , 2005, Nature Genetics.
[55] Tyson V. Sharp,et al. LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[56] Elliott Kieff,et al. Role of NF-κB in Cell Survival and Transcription of Latent Membrane Protein 1-Expressing or Epstein-Barr Virus Latency III-Infected Cells , 2004, Journal of Virology.
[57] K. Takada,et al. An Epstein-Barr virus-producer line Akata: Establishment of the cell line and analysis of viral DNA , 1991, Virus Genes.
[58] M. Piris,et al. Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study. , 2004, The American journal of pathology.
[59] Y. Natkunam,et al. Expression of the B-Cell Proliferation Marker MUM1 by Melanocytic Lesions and Comparison with S100, gp100 (HMB45), and MelanA , 2003, Modern Pathology.
[60] C. Chang,et al. Expression of MUM1/IRF4 correlates with clinical outcome in patients with B-cell chronic lymphocytic leukemia. , 2002, Blood.
[61] Sonia Sharma,et al. Repression of IRF-4 target genes in human T cell leukemia virus-1 infection , 2002, Oncogene.
[62] T. Waldmann,et al. Regulation of IFN Regulatory Factor 4 Expression in Human T Cell Leukemia Virus-I-Transformed T Cells1 , 2002, The Journal of Immunology.
[63] John Crowley,et al. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. , 2002, Blood.
[64] Sonia Sharma,et al. IRF-4 activities in HTLV-I-induced T cell leukemogenesis. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[65] J. Bartlett,et al. Activation and regulation of interferon regulatory factor 4 in HTLV type 1-infected T lymphocytes. , 2000, AIDS research and human retroviruses.
[66] J. Hiscott,et al. Posttranslational regulation of IRF-4 activity by the immunophilin FKBP52. , 2000, Immunity.
[67] B. Klein,et al. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma , 1997, Nature Genetics.
[68] J. Sample,et al. Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein , 1996, Journal of virology.
[69] U. Storb,et al. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. , 1995, Genes & development.
[70] M. Masucci,et al. B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: studies with somatic cell hybrids. , 1991, The Journal of general virology.
[71] J. Lawrence,et al. The prototypical Epstein-Barr virus-transformed lymphoblastoid cell line IB4 is an unusual variant containing integrated but no episomal viral DNA , 1991, Journal of virology.